Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 14, 2022; 28(22): 2437-2456
Published online Jun 14, 2022. doi: 10.3748/wjg.v28.i22.2437
Published online Jun 14, 2022. doi: 10.3748/wjg.v28.i22.2437
Figure 2 Effect of 18β-glycyrrhetinic acid on survival rate of GES-1 cells and proliferation of MGC80-3 and BGC-823 cells detected by CCK-8 method.
A: GES-1 cells; B: BGC-823 cells; C: MGC80-3 cells; D: IC50 values of 18β-glycyrrhetinic acid (18β-GRA) for BGC-823 cells and MGC80-3 cells after 24 h, 48 h, and 72 h; E and F: Inhibition rate of 18β-GRA acid at different concentrations on BGC-823 and MGC80-3 cell proliferation. All analyses were repeated three times. The data is represented as the mean ± SD. aP < 0.05; bP < 0.01; cP < 0.001. 18β-GRA: 18β-glycyrrhetinic acid.
- Citation: Yuan L, Yang Y, Li X, Zhou X, Du YH, Liu WJ, Zhang L, Yu L, Ma TT, Li JX, Chen Y, Nan Y. 18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells. World J Gastroenterol 2022; 28(22): 2437-2456
- URL: https://www.wjgnet.com/1007-9327/full/v28/i22/2437.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i22.2437